LeMaitre Vascular, Inc. — Q3 2026 Earnings Summary

LeMaitre Vascular reported third-quarter 2026 net sales of $68.0 million, representing an 11% increase over the prior year period. The company achieved a gross margin of 71.7% and reported earnings per share of $0.65, while announcing a quarterly dividend of $0.25 per share. Growth was driven by a 20% increase in graft sales and an 18% rise in EMEA revenue, alongside the recent acquisition of vascular assets from B. Braun. Management provided full-year 2026 guidance projecting sales between $274.8 million and $276.8 million and adjusted EPS between $2.77 and $2.82.